Adverse Events Associated With New Injectable-Free Multidrug-Resistant Tuberculosis Drug Regimens.
Carreras-Abad C, Espiau M, López-Seguer L, Martín-Begué N, Martín-Nalda A, Melendo-Pérez S, Mendoza-Palomar N, Soler-Palacin P, Schaaf HS, Soriano-Arandes A.
Carreras-Abad C, et al.
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):823-825. doi: 10.1016/j.arbres.2020.07.006. Epub 2020 Aug 13.
Arch Bronconeumol (Engl Ed). 2020.
PMID: 32800388
English, Spanish.
No abstract available.